Mutational Analysis in Non-Small Cell Lung Cancer

Director of the Thoracic Oncology Program at the Abramson Cancer Center, Corey Langer, MD, discusses recent interpretations of the mutational profile for non-small cell lung cancer (NSCLC), what this knowledge reveals about the patient population, and how it is being translated into clinical trials for new therapies targeting specific mutations in NSCLC.